For research use only
| Cat No. | ABC-TC510S |
| Product Type | Human Esophageal Cancer Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Esophagus |
| Disease | Esophageal Cancer |
| Product Code | OE-33; JROECL 33; JROECL33; OEC33 |
OE33 cells, from esophageal adenocarcinoma, express MHC I, ICAM-1, cytokeratins, and are tumorigenic, modeling Barrett’s metaplasia progression.
| Product Code | OE-33; JROECL 33; JROECL33; OEC33 |
| Species | Human |
| Cat.No | ABC-TC510S |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Esophagus |
| Disease | Esophageal Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Esophageal Cancer Cell Lines |
OE33 is a valuable in vitro model for investigating the molecular biology of esophageal adenocarcinoma, including tumor progression, immune response, and drug resistance. It is widely used in xenograft models for preclinical evaluation of chemotherapeutic agents such as cisplatin and 5-Fluorouracil, as well as for testing targeted therapies. OE33 is employed to investigate epithelial-mesenchymal transition (EMT) markers, cytokine signaling within tumor microenvironments, and oncogenic pathways involving HER2/EGFR alterations. Its relevance to Barrett’s-associated adenocarcinoma progression further enhances its utility in translational cancer research.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
